Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
PHASE2CompletedINTERVENTIONAL
Enrollment
14
Participants
Timeline
Start Date
June 30, 2005
Primary Completion Date
November 30, 2008
Study Completion Date
March 31, 2012
Conditions
Stage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Squamous Cell Carcinoma of the Oropharynx
Interventions
DRUG
romidepsin
Given IV
Trial Locations (2)
02115
Dana-Farber Cancer Institute, Boston
10467-2490
Montefiore Medical Center, The Bronx
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00084682 - Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter | Biotech Hunter